EP07 Co Investing in the Storm: Rethinking Capital Partnerships in Early St

Описание: In this episode, I speak with Peter M. Kovacs and Thijmen Meijer about co-investors in early-stage MedTech and BioTech.

We cut through labels and focus on what actually matters: skin in the game, trust, and execution.
What we cover:
Why investor type matters less than incentives, capability, and character
Two co-investor profiles that create the strongest execution synergies
Peter’s view on family offices: values first, personal trust, relationship over transaction
Thijmen’s reality check: introductions beat cold outreach
Why focused micro funds and emerging managers can outperform fee-driven models
What real de-risking looks like when you are building under pressure
If you are a founder, LP, family office, or emerging manager looking for clarity over hype, this conversation is for you.

Timecode:
00:00 Introduction to Key Stakeholders
00:22 Types of Co-Investors
01:09 Value Proposition and Commitment
02:10 Investor Specialization and Synergies
03:26 Role of Angel Investors
04:02 Corporate Venture Capital
04:44 Family Offices and Personal Touch
08:56 Challenges in Different Regions
09:32 Building Relationships with Investors
10:34 High Net Worth Individuals
18:02 Micro Funds and Emerging Managers
19:51 Conclusion and Future Outlook

Links:
Karoly Szanto LinkedIn:   / karolyszanto1  
Karoly Szanto Personal Website: https://www.karolyszanto.com/
UniPrisma: https://uniprisma.com/

Guests:
Thijmen Meijer: https://www.thijmenmeijer.com/
Peter M. Kovacs Personal Website:https://www.petermkovacs.com/